ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
INTUITIVE SURGICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026
$433.18+6.48 (+1.52%)
Close on Oct 19, 2026
- Market cap
- $154.78B
- P/E (TTM)
- 49.6
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
86.9%
307M of 353M shares
Institutional holders
2,247
180 new, 212 sold out
Net institutional buying
8M
In Q2 2026
Insider trades, 12 months
0 buys · 83 sales
Net sold $93.42M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 29,575,972 | 8.40% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Capital Management | 26,601,419 | 7.49% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ISRG | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 30,024,648 | 8.50% | $11.94B | −51,257 | 0.18% |
| Vanguard Capital Management LLC | 23,131,099 | 6.55% | $9.20B | +51,609 | 0.20% |
| State Street Corp | 16,063,040 | 4.55% | $6.39B | +216,067 | 0.19% |
| Invesco Ltd. | 11,843,563 | 3.35% | $4.71B | +653,078 | 0.37% |
| Price T Rowe Associates Inc /Md/ | 11,256,570 | 3.19% | $4.48M | −1,263,437 | 0.45% |
| Geode Capital Management, LLC | 8,534,767 | 2.42% | $3.38B | +67,916 | 0.18% |
| Capital World Investors | 7,742,681 | 2.19% | $3.08B | −305,329 | 0.36% |
| Vanguard Portfolio Management LLC | 7,243,264 | 2.05% | $2.88B | +9,293 | 0.13% |
| Morgan Stanley | 6,561,322 | 1.86% | $2.61B | +502,482 | 0.14% |
| Norges Bank | 4,954,874 | 1.40% | $1.97B | New | 0.20% |
| FMR LLC | 4,251,130 | 1.20% | $1.69B | −1,226,104 | 0.07% |
| JPMorgan Chase & Co | 4,231,033 | 1.20% | $1.72B | −362,861 | 0.10% |
| Fisher Asset Management, LLC | 3,918,840 | 1.11% | $1.56B | +65,900 | 0.46% |
| Wellington Management Group Llp | 3,802,003 | 1.08% | $1.51B | −157,287 | 0.26% |
| Arrowstreet Capital, Limited Partnership | 3,744,497 | 1.06% | $1.49B | +1,638,953 | 0.66% |
| Jennison Associates LLC | 3,669,211 | 1.04% | $1.46B | +628,201 | 0.88% |
| Alliancebernstein L.P. | 3,632,766 | 1.03% | $1.67B | −179,897 | 0.55% |
| Northern Trust Corp | 3,512,996 | 0.99% | $1.40B | +8,724 | 0.16% |
| Bank Of America Corp /De/ | 3,403,759 | 0.96% | $1.35B | −213,214 | 0.09% |
| Bank of New York Mellon Corp | 3,358,863 | 0.95% | $1.34B | −191,512 | 0.22% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2,247 | 307M | 86.9% | 180 / 903 | 882 / 212 | 26M | 18M |
| Q1 2026 | 2,319 | 301M | 85.1% | 179 / 994 | 836 / 245 | 50M | 25M |
| Q4 2025 | 2,416 | 311M | 87.9% | 456 / 975 | 716 / 110 | 35M | 20M |
| Q3 2025 | 2,117 | 297M | 84.1% | 149 / 852 | 814 / 265 | 20M | 31M |
| Q2 2025 | 2,270 | 308M | 87.3% | 217 / 1037 | 701 / 112 | 19M | 14M |
| Q1 2025 | 2,194 | 304M | 86.0% | 232 / 949 | 713 / 135 | 17M | 15M |
| Q4 2024 | 2,135 | 305M | 86.4% | 289 / 824 | 711 / 77 | 14M | 21M |
| Q3 2024 | 1,955 | 312M | 88.3% | 223 / 762 | 653 / 71 | 45M | 17M |
| Q2 2024 | 1,825 | 315M | 89.1% | 183 / 785 | 584 / 79 | 20M | 22M |
| Q1 2024 | 1,743 | 318M | 90.0% | 205 / 708 | 592 / 105 | 25M | 15M |
| Q4 2023 | 1,674 | 309M | 87.4% | 249 / 631 | 562 / 100 | 26M | 12M |
| Q3 2023 | 1,552 | 295M | 83.5% | 123 / 648 | 514 / 114 | 16M | 17M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ISRG | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 11,243,468 | 3.18% | $4.47B | 0.19% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 9,176,409 | 2.60% | $3.65B | 0.22% | Jun 30, 2026 |
| Invesco QQQ Trust, Series 1 | 7,517,879 | 2.13% | $2.99B | 0.61% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 4,871,812 | 1.38% | $1.94B | 0.22% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 4,544,606 | 1.29% | $1.93B | 0.23% | May 31, 2026 |
| Vanguard Growth Index Fund | 3,848,611 | 1.09% | $1.53B | 0.40% | Jun 30, 2026 |
| Growth Fund of America | 2,749,535 | 0.78% | $1.17B | 0.32% | May 31, 2026 |
| Vanguard Health Care Fund | 2,725,449 | 0.77% | $962.98M | 2.52% | Jul 31, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 2,502,083 | 0.71% | $995.03M | 2.45% | Jun 30, 2026 |
| New Perspective Fund | 2,309,555 | 0.65% | $918.46M | 0.54% | Jun 30, 2026 |
| Vanguard Institutional Index Fund | 1,922,661 | 0.54% | $764.60M | 0.22% | Jun 30, 2026 |
| Growth Fund | 1,637,533 | 0.46% | $651.21M | 1.14% | Jun 30, 2026 |
| Invesco NASDAQ 100 ETF | 1,508,672 | 0.43% | $640.64M | 0.66% | May 31, 2026 |
| T. Rowe Price Blue Chip Growth Fund, Inc. | 1,444,506 | 0.41% | $574.45M | 0.89% | Jun 30, 2026 |
| iShares Russell 1000 Growth ETF | 1,346,304 | 0.38% | $535.40M | 0.42% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David J. Rosa | Chief Executive Officer (CEO), Director | 247,803 | 0.07% | Jul 13, 2026 |
| Fredrik Widman | VP Corporate Controller | 1,569 | 0.00% | Sep 16, 2026 |
| Mark Brosius | EVP & Chief Mfg and Supply Cha | 764 | 0.00% | Sep 11, 2026 |
| Gary Loeb | EVP & Chief Legal and Complian | 5,320 | 0.00% | Aug 10, 2026 |
| Iman Jeddi | SVP & GM da Vinci Platforms & | 38,737 | 0.01% | Jun 2, 2026 |
| Myriam Curet | EVP & Chief Medical Officer | 514 | 0.00% | Mar 11, 2026 |
| Jamie Samath | EVP & CFO & Enterprise Technol | 15,366 | 0.00% | Mar 2, 2026 |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | 5,972 | 0.00% | Mar 2, 2026 |
| Patricia L. Wadors | SVP Chief Human Resources Offi | 0 | – | Feb 27, 2026 |
| Brian Edward Miller | EVP & Chief Digital Officer | 5,758 | 0.00% | Nov 12, 2025 |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 5,412 | 0.00% | Apr 29, 2025 |
| Gary S. Guthart | Director | 1,288,876 | 0.36% | Aug 12, 2026 |
| Amy L. Ladd | Director | 179 | 0.00% | Aug 11, 2026 |
| Lewis Chew | Director | 1,314 | 0.00% | Apr 30, 2026 |
| Craig H. Barratt | Director | 28,698 | 0.01% | Apr 30, 2026 |
| Sreelakshmi Kolli | Director | 1,510 | 0.00% | Apr 30, 2026 |
| Amal M. Johnson | Director | 13,545 | 0.00% | Apr 30, 2026 |
| Keith R. Leonard | Director | 901 | 0.00% | Apr 30, 2026 |
| Jami K. Nachtsheim | Director | 6,902 | 0.00% | Apr 30, 2026 |
| Joseph C. Beery | Director | 3,641 | 0.00% | Apr 30, 2026 |
| Monica P. Reed | Director | 2,876 | 0.00% | Apr 30, 2026 |
| Mark J. Rubash | Director | 16,790 | 0.00% | Apr 25, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Fredrik Widman VP Corporate Controller | Sep 15, 2026 | Option exercise | +543 | $109.49 | $59.45K | 1,569 |
| Fredrik Widman VP Corporate Controller | Sep 15, 2026 | Sale(10b5-1 plan) | −546 | $374.44 | $204.44K | 1,026 |
| Fredrik Widman VP Corporate Controller | Sep 15, 2026 | Option exercise | +546 | $79.64 | $43.48K | 1,572 |
| Fredrik Widman VP Corporate Controller | Sep 15, 2026 | Sale(10b5-1 plan) | −543 | $374.44 | $203.32K | 1,026 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Sep 11, 2026 | Sale(10b5-1 plan) | −25 | $365.79 | $9.14K | 764 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Sep 10, 2026 | Sale(10b5-1 plan) | −23 | $347.66 | $8.00K | 789 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Sep 9, 2026 | Sale(10b5-1 plan) | −23 | $350.20 | $8.05K | 812 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Sep 8, 2026 | Sale(10b5-1 plan) | −46 | $361.23 | $16.62K | 835 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Aug 21, 2026 | Sale(10b5-1 plan) | −77 | $375.57 | $28.92K | 881 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Aug 20, 2026 | Sale(10b5-1 plan) | −77 | $396.37 | $30.52K | 958 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Aug 19, 2026 | Sale(10b5-1 plan) | −77 | $394.26 | $30.36K | 1,035 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Aug 18, 2026 | Sale(10b5-1 plan) | −77 | $394.00 | $30.34K | 1,112 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Aug 17, 2026 | Sale(10b5-1 plan) | −77 | $390.67 | $30.08K | 1,189 |
| Gary S. Guthart Director | Aug 11, 2026 | Sale(10b5-1 plan) | −10,000 | $400.00 | $4.00M | 1,245,679 |
| Amy L. Ladd Director | Aug 11, 2026 | Sale(10b5-1 plan) | −72 | $393.10 | $28.30K | 179 |
| Amy L. Ladd Director | Aug 10, 2026 | Sale(10b5-1 plan) | −400 | $379.00 | $151.60K | 251 |
| Gary Loeb EVP & Chief Legal and Complian | Aug 10, 2026 | Sale(10b5-1 plan) | −400 | $379.00 | $151.60K | 5,320 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Jul 31, 2026 | Sale(10b5-1 plan) | −28 | $351.00 | $9.83K | 1,266 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Jul 30, 2026 | Sale(10b5-1 plan) | −28 | $346.83 | $9.71K | 1,294 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Jul 29, 2026 | Sale(10b5-1 plan) | −28 | $360.21 | $10.09K | 1,322 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Jul 28, 2026 | Sale(10b5-1 plan) | −28 | $365.58 | $10.24K | 1,350 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Jul 27, 2026 | Sale(10b5-1 plan) | −28 | $344.00 | $9.63K | 1,378 |
| David J. Rosa Chief Executive Officer (CEO), Director | Jul 10, 2026 | Option exercise | +1,910 | – | – | 247,803 |
| David J. Rosa Chief Executive Officer (CEO), Director | Jul 10, 2026 | Tax withholding | −947 | $411.55 | $389.74K | 246,856 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Jun 12, 2026 | Sale(10b5-1 plan) | −25 | $414.13 | $10.35K | 1,406 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Jun 11, 2026 | Sale(10b5-1 plan) | −23 | $412.16 | $9.48K | 1,431 |
| David J. Rosa Chief Executive Officer (CEO), Director | Jun 10, 2026 | Tax withholding | −674 | $426.61 | $287.54K | 245,893 |
| David J. Rosa Chief Executive Officer (CEO), Director | Jun 10, 2026 | Option exercise | +1,358 | – | – | 246,567 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Jun 10, 2026 | Sale(10b5-1 plan) | −23 | $424.14 | $9.76K | 1,454 |
| Gary Loeb EVP & Chief Legal and Complian | Jun 10, 2026 | Sale(10b5-1 plan) | −400 | $424.14 | $169.66K | 5,720 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Jun 9, 2026 | Sale(10b5-1 plan) | −23 | $421.13 | $9.69K | 1,477 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | Jun 8, 2026 | Sale(10b5-1 plan) | −23 | $420.12 | $9.66K | 1,500 |
| Iman Jeddi SVP & GM da Vinci Platforms & | Jun 1, 2026 | Option exercise | +5,625 | $77.00 | $433.13K | 12,088 |
| Iman Jeddi SVP & GM da Vinci Platforms & | Jun 1, 2026 | Sale(10b5-1 plan) | −5,625 | $420.55 | $2.37M | 6,463 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | May 22, 2026 | Sale(10b5-1 plan) | −18 | $439.80 | $7.92K | 1,523 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | May 21, 2026 | Sale(10b5-1 plan) | −18 | $446.04 | $8.03K | 1,541 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | May 20, 2026 | Sale(10b5-1 plan) | −18 | $440.38 | $7.93K | 1,559 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | May 19, 2026 | Sale(10b5-1 plan) | −18 | $440.70 | $7.93K | 1,577 |
| Mark Brosius EVP & Chief Mfg and Supply Cha | May 18, 2026 | Sale(10b5-1 plan) | −18 | $422.47 | $7.60K | 1,595 |
| Gary Loeb EVP & Chief Legal and Complian | May 11, 2026 | Sale(10b5-1 plan) | −400 | $446.95 | $178.78K | 6,120 |
| Monica P. Reed Director | Apr 30, 2026 | Option exercise | +531 | – | – | 2,876 |
| Keith R. Leonard Director | Apr 30, 2026 | Option exercise | +531 | – | – | 901 |
| Sreelakshmi Kolli Director | Apr 30, 2026 | Option exercise | +531 | – | – | 1,510 |
| Craig H. Barratt Director | Apr 30, 2026 | Option exercise | +750 | – | – | 27,948 |
| Amal M. Johnson Director | Apr 30, 2026 | Option exercise | +531 | – | – | 13,545 |
| Lewis Chew Director | Apr 30, 2026 | Option exercise | +531 | – | – | 1,314 |
| Jami K. Nachtsheim Director | Apr 30, 2026 | Option exercise | +531 | – | – | 6,902 |
| Amy L. Ladd Director | Apr 30, 2026 | Option exercise | +531 | – | – | 651 |
| Joseph C. Beery Director | Apr 30, 2026 | Option exercise | +531 | – | – | 3,641 |
| Amy L. Ladd Director | Apr 29, 2026 | Sale(10b5-1 plan) | −119 | $463.50 | $55.16K | 120 |
| Amy L. Ladd Director | Apr 28, 2026 | Sale(10b5-1 plan) | −500 | $473.46 | $236.73K | 239 |
| Myriam Curet EVP & Chief Medical Officer | Mar 10, 2026 | Option exercise | +105 | $229.39 | $24.09K | 105 |
| Myriam Curet EVP & Chief Medical Officer | Mar 10, 2026 | Sale(10b5-1 plan) | −105 | $493.95 | $51.86K | 0 |
| Mark Brosius SVP & Chief Mfg and Supply Cha | Mar 9, 2026 | Sale(10b5-1 plan) | −645 | $485.01 | $312.83K | 1,613 |
| Mark Brosius SVP & Chief Mfg and Supply Cha | Mar 6, 2026 | Sale(10b5-1 plan) | −648 | $490.19 | $317.64K | 2,258 |
| Mark Brosius SVP & Chief Mfg and Supply Cha | Mar 5, 2026 | Sale(10b5-1 plan) | −648 | $495.20 | $320.89K | 2,906 |
| Mark Brosius SVP & Chief Mfg and Supply Cha | Mar 4, 2026 | Sale(10b5-1 plan) | −2,362 | $498.68 | $1.18M | 3,554 |
| Mark Brosius SVP & Chief Mfg and Supply Cha | Mar 3, 2026 | Sale(10b5-1 plan) | −648 | $488.10 | $316.29K | 5,916 |
| Myriam Curet EVP & Chief Medical Officer | Mar 3, 2026 | Sale(10b5-1 plan) | −4,728 | $487.18 | $2.30M | 409 |
| Fredrik Widman VP Corporate Controller | Mar 3, 2026 | Sale(10b5-1 plan) | −118 | $487.18 | $57.49K | 1,026 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Widman Fredrik Officer | Sep 15, 2026 | 2,178 | $823.15K | Sep 15, 2026 | Exercise of Stock Options |
| Brosius Mark Officer | Sep 8, 2026 | 694 | $254.49K | Sep 8, 2026 | Performance Stock Units |
| Family Trust Guthart Director | Aug 11, 2026 | 20,095 | $7.90M | Aug 11, 2026 | RSU/PSU |
| L. Ladd Amy Director | Aug 10, 2026 | 472 | $178.80K | Aug 10, 2026 | Restricted Stock Units |
| Loeb Gary Officer | Aug 10, 2026 | 400 | $151.52K | Aug 10, 2026 | Restricted Stock Units |
| Loeb Gary Officer | Jun 10, 2026 | 400 | $170.64K | Jun 10, 2026 | Restricted Stock Units |
| Brosius Mark Officer | Jun 8, 2026 | 665 | $280.67K | Jun 8, 2026 | Performance Stock Units |
| Johnson Amal Director | Jun 3, 2026 | 12,472 | $5.02M | Jun 3, 2026 | Exercise of Stock Options |
| Jeddi Iman Officer | Jun 1, 2026 | 5,625 | $2.37M | Jun 1, 2026 | Stock Option Exercise |
| Loeb Gary Officer | May 11, 2026 | 400 | $180.02K | May 11, 2026 | Restricted Stock Units |
| Ladd Amy Director | Apr 28, 2026 | 619 | $291.54K | Apr 28, 2026 | Restricted Stock Units |
| Family Revocable Living Tr U/A Dtd 01/28/2009 McAdams Former Officer | Apr 27, 2026 | 30,417 | $14.32M | Apr 27, 2026 | Stock Option Exercise |
| Curet McAdams Myriam Officer | Mar 10, 2026 | 105 | $51.86K | Mar 10, 2026 | Stock Option Exercise |
| Brosius Mark Officer | Mar 5, 2026 | 1,714 | $859.02K | Mar 5, 2026 | Performance Stock Units |
| Miller Brian Officer | Mar 4, 2026 | 8,368 | $4.16M | Mar 4, 2026 | Restricted Stock Units |